GlassScriptPhysician profile
Gustavo Lara
NPI 1639132392
$10,017.78
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,029 · 2020: $242 · 2021: $133 · 2022: $129 · 2023: $60.57 · 2024: $120 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,217.68 | 2019-2022 | |
| Elucent Medical | $137.51 | 2025 | |
| Karl Storz Endoscopy-America | $121.99 | 2020 | |
| Smith+Nephew, INC. | $70.68 | 2025 | Stravix |
| Medtronic, INC. | $52.24 | 2021-2025 | Progrip |
| Tela Bio, INC. | $51.43 | 2024 | Ovitex 2s |
| Bard Peripheral Vascular, INC. | $46.26 | 2022-2023 | Venclose Maven Catheter |
| Innocoll Pharmaceuticals Limited | $45.67 | 2021 | |
| Integra Lifesciences Corporation | $32.87 | 2024 | Integra, Omnigraft, Surgimend |
| Trevena, INC. | $32.69 | 2021 | |
| Mimedx Group, INC. | $23.80 | 2025 | |
| Abbvie INC. | $22.95 | 2020 | |
| Tactile Systems Technology INC | $21.74 | 2025 | Flexitouch Plus, Nimbl |
| Laminate Medical Technologies INC. | $21.00 | 2025 | Vasq |
| Aroa Biosurgery Incorporated | $20.76 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $19.67 | 2020 | |
| Baxter Healthcare | $18.27 | 2023 | Preveleak |
| Ethicon US, LLC | $15.86 | 2025 | Evarrest |
| Silk Road Medical, INC. | $15.38 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Galvanize Therapeutics, INC | $15.29 | 2024 | Aliya System |
| Covidien LP | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gustavo Lara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.